Seventure Partners invests in Domain Therapeutics
Domain Therapeutics said May 28 that it secured a 3.5 million euros ($3.9 million) investment from existing shareholder Seventure Partners. Domain is a French biopharma company that is involved in the discovery and early development of programs targeting membrane receptors in central nervous system (CNS) disorders, oncology/immuno-oncology and rare diseases.
28 May 2019•3 mins read
